David Porter
Impact in
- Hematology top 0.05%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Oncology top 0.2%
- CAR-T cell therapy research
Papers in
- Hematology 112
- Hematopoietic Stem Cell Transplantation 86
- Acute Myeloid Leukemia Research 34
- Biomaterials 48
- Silk-based biomaterials and applications 45
- Co-authors
- Fritz W. Vollrath (42 shared papers)Stephan A. Grupp (12 shared papers)Arthur H. Heuer (5 shared papers)Carl H. June (21 shared papers)Daniel W. Lee (1 shared paper)Rebecca Alice Gardner (1 shared paper)Crystal L. Mackall (1 shared paper)Chrystal Ursula Louis (1 shared paper)
- Journals
- Blood (39 papers)Transplantation and Cellular Therapy (29 papers)Journal of Nuclear Materials (29 papers)Bone Marrow Transplantation (19 papers)Polymer (11 papers)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
David Porter
321 papers receiving 23.2k citations
David Porter's Hit Papers
Peers
Comparison fields: 5 of 195
- Hematology 7.3k
- Oncology 8.1k
- Biomaterials 3.5k
- Immunology 4.9k
- Transplantation 603
Countries citing papers authored by David Porter
This map shows the geographic impact of David Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Porter more than expected).
Fields of papers citing papers by David Porter
This network shows the impact of papers produced by David Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Porter. The network helps show where David Porter may publish in the future.
Co-authors
The 25 scholars most cited alongside David Porter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 337 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Current concepts in the diagnosis and management of cytokine release syndrome Hit paper breakdown → | 2014 | 2324 |
| 2 | Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia Hit paper breakdown → | 2015 | 1482 |
| 3 | Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. Hit paper breakdown → | 1997 | 1077 |
| 4 | Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells Hit paper breakdown → | 2018 | 736 |
| 5 | Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors Hit paper breakdown → | 2012 | 713 |
| 6 | International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium Hit paper breakdown → | 2015 | 709 |
| 7 | Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia Hit paper breakdown → | 2015 | 550 |
| 8 | Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes Hit paper breakdown → | 2017 | 537 |
| 9 | Antibody-modified T cells: CARs take the front seat for hematologic malignancies Hit paper breakdown → | 2014 | 529 |
| 10 | 1994 | 424 | |
| 11 | 2015 | 373 | |
| 12 | 1977 | 368 | |
| 13 | Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease Hit paper breakdown → | 2019 | 352 |
| 14 | 2014 | 337 | |
| 15 | 1979 | 334 | |
| 16 | 2011 | 305 | |
| 17 | 2001 | 305 | |
| 18 | 2005 | 256 | |
| 19 | 2009 | 245 | |
| 20 | 2006 | 238 |
About David Porter
David Porter is a scholar working on Hematology, Biomaterials, Oncology, Immunology and Materials Chemistry, having authored 337 papers that have together received 24.0k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (86 papers), Silk-based biomaterials and applications (45 papers), Nuclear Materials and Properties (43 papers), CAR-T cell therapy research (36 papers), Acute Myeloid Leukemia Research (34 papers), Nuclear reactor physics and engineering (33 papers), Immune Cell Function and Interaction (30 papers) and Fusion materials and technologies (26 papers). The work is most often cited by research in Hematology (7.3k citations), Oncology (8.1k citations), Biomaterials (3.5k citations), Immunology (4.9k citations) and Transplantation (603 citations). David Porter has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Fritz W. Vollrath, Stephan A. Grupp, Arthur H. Heuer, Carl H. June, Daniel W. Lee, Rebecca Alice Gardner, Crystal L. Mackall, Chrystal Ursula Louis, Nabil M. Ahmed and Michael C. Jensen. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, Journal of Nuclear Materials, Bone Marrow Transplantation and Polymer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.